These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 871648)

  • 1. Absorption of lithium from controlled-release preparations.
    Scott MR
    Br Med J; 1977 Jun; 1(6075):1533. PubMed ID: 871648
    [No Abstract]   [Full Text] [Related]  

  • 2. Absorption of lithium following administration of slow-release and conventional preparations.
    Tyrer S; Hullin RP; Birch NJ; Goodwin JC
    Psychol Med; 1976 Feb; 6(1):51-8. PubMed ID: 935297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium absorption from sustained-release tablets (Duretter).
    Amdisen A; Sjögren J
    Acta Pharm Suec; 1968 Nov; 5(5):465-72. PubMed ID: 5732567
    [No Abstract]   [Full Text] [Related]  

  • 4. Lithium absorption from ordinary and from sustained-release tablets.
    Otto U; Paalzow L; Surén G
    Acta Pharm Suec; 1972 Dec; 9(6):595-601. PubMed ID: 4656566
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioavailability of lithium carbonate and lithium citrate: a comparison of two controlled-release preparations.
    Tyrer SP; Peat MA; Minty PS; Luchini A; Glud V; Amdisen A
    Pharmatherapeutica; 1982; 3(4):243-6. PubMed ID: 6815664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations.
    Arancibia A; Corvalan F; Mella F; Concha L
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):240-5. PubMed ID: 3089949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium absorption: implications for sustained-release lithium preparations.
    Ehrlich BE; Diamond JM
    Lancet; 1983 Feb; 1(8319):306. PubMed ID: 6130326
    [No Abstract]   [Full Text] [Related]  

  • 8. The single-dose bioavailability of different lithium carbonate products.
    Tsang HY; Chen CC; Wen JK
    Taiwan Yi Xue Hui Za Zhi; 1987 May; 86(5):543-8. PubMed ID: 3114414
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of a slow-release lithium carbonate formulation.
    Cooper TB; Simpson GM; Lee JH; Bergner PE
    Am J Psychiatry; 1978 Aug; 135(8):917-22. PubMed ID: 665833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution and saliva concentrations of some lithium dosage forms.
    Wall BP; Parkin JE; Sunderland VB; Zorbas A
    J Pharm Pharmacol; 1982 Sep; 34(9):601-3. PubMed ID: 6127391
    [No Abstract]   [Full Text] [Related]  

  • 11. Absorption & urinary & salivary excretion of lithium after oral administration.
    Doshi BS; Rout SJ; Kulkarni RD
    Indian J Med Res; 1983 Nov; 78():708-12. PubMed ID: 6423533
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bioavailability of lithium from tablets containing different lithium salts].
    Leucuţa S; Fodoreanu L; Pop R; Barna D; Kovãcs A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1982; 27(2):145-8. PubMed ID: 6216569
    [No Abstract]   [Full Text] [Related]  

  • 13. A pharmacokinetic analysis of lithium carbonate absorption from several formulations in man.
    Caldwell HC; Westlake WJ; Connor SM; Flanagan T
    J Clin Pharmacol New Drugs; 1971; 11(5):349-56. PubMed ID: 5208514
    [No Abstract]   [Full Text] [Related]  

  • 14. Aspect of the pharmacokinetics of slow-release lithium carbonate.
    Hart GA
    S Afr Med J; 1984 Aug; 66(5):178-9. PubMed ID: 6431618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preformulation study of controlled release nitrofurantoin preparations. 2].
    Marton S; Nguyen Thi Minh Tam ; Antal I; Rácz I
    Acta Pharm Hung; 1990 May; 60(2-3):57-67. PubMed ID: 2386073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose pharmacokinetics of a controlled release lithium preparation "Liskonum" in African patients suffering from manic depressive psychosis.
    Mengech HN; Ojwang PJ
    East Afr Med J; 1984 Apr; 61(4):321-5. PubMed ID: 6489236
    [No Abstract]   [Full Text] [Related]  

  • 17. Single-dose bioavailability of two extended-release lithium carbonate products.
    Kirkwood CK; Wilson SK; Hayes PE; Barr WH; Sarkar MA; Ettigi PG
    Am J Hosp Pharm; 1994 Feb; 51(4):486-9. PubMed ID: 8017413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of whole and half Theo-Dur tablets.
    Fagerström PO
    Eur J Respir Dis Suppl; 1980; 109():62-6. PubMed ID: 6934089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum lithium levels after slow-release and regular tablets of lithium carbonate].
    Kauko K; Viukari M
    Duodecim; 1973; 89(19):1324-8. PubMed ID: 4757404
    [No Abstract]   [Full Text] [Related]  

  • 20. Per-oral controlled release dosage form of theophylline using soybean protein.
    Machida Y; Tokumura T; Nagai T
    Drug Des Deliv; 1987 Feb; 1(3):187-92. PubMed ID: 3509332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.